Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - solifenacin succinate, quantity: 10 mg - tablet - excipient ingredients: maize starch; hypromellose; purified talc; magnesium stearate; lactose monohydrate; titanium dioxide; propylene glycol; iron oxide yellow; iron oxide red - solifenacin succinate is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - solifenacin succinate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; purified talc; hypromellose; magnesium stearate; titanium dioxide; propylene glycol; iron oxide yellow - solifenacin succinate is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 5 mg (equivalent: solifenacin, qty 3.8 mg) - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; titanium dioxide; iron oxide yellow; pregelatinised maize starch; lactose monohydrate; purified talc; macrogol 6000 - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 10 mg (equivalent: solifenacin, qty 7.5 mg) - tablet, film coated - excipient ingredients: iron oxide red; purified talc; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; magnesium stearate; macrogol 6000 - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 5 mg (equivalent: solifenacin, qty 3.8 mg) - tablet, film coated - excipient ingredients: iron oxide yellow; macrogol 6000; magnesium stearate; lactose monohydrate; titanium dioxide; hypromellose; pregelatinised maize starch; purified talc - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - solifenacin succinate, quantity: 10 mg (equivalent: solifenacin, qty 7.5 mg) - tablet, film coated - excipient ingredients: purified talc; macrogol 6000; lactose monohydrate; hypromellose; magnesium stearate; pregelatinised maize starch; iron oxide red; titanium dioxide - solifenacin sandoz is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - solifenacin succinate, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; lactose monohydrate; hypromellose; titanium dioxide; purified talc; macrogol 6000; iron oxide red - solifenacin lupin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - solifenacin succinate, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; maize starch; hypromellose; titanium dioxide; purified talc; iron oxide yellow; macrogol 6000 - solifenacin lupin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - solifenacin succinate, quantity: 5 mg - tablet - excipient ingredients: maize starch; purified talc; lactose monohydrate; hypromellose; magnesium stearate; titanium dioxide; propylene glycol; iron oxide yellow - solifenacin succinate is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - solifenacin succinate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - solifenacin succinate is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.